Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997;93(4):317-26.
doi: 10.1007/BF02569069.

Low Dose Radiation for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration. A Pilot Study: Radiotherapy for Age-Related Macular Degeneration

Affiliations
Clinical Trial

Low Dose Radiation for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration. A Pilot Study: Radiotherapy for Age-Related Macular Degeneration

C Valmaggia et al. Doc Ophthalmol. .

Abstract

The aim of our pilot study was to test the effect of low dose radiation on classic and occult subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD). The posterior pole of the afflicted eye of 12 patients was irradiated with 5 Gray (Gy), and that of 34 patients with 8 Gy. The radiotherapy was done by a linear accelerator (6 MV X-rays) during 4 consecutive days with daily doses of 1.25 Gy and 2 Gy respectively. At the time of treatment, and 6 weeks, 6 months and 1 year after, a simultaneous fluorescein and ICG angiography of both eyes were carried out, and the distance visual acuity was measured. In none of the cases were we able to note a reduction in the subfoveal membrane's size. With regards to the visual acuity, the evolution was slightly better than the spontaneous courses described in existing literature. Further prospective randomized studies with higher dose radiation are necessary in order to determine the significance of radiotherapy in the treatment of this pathology.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Br J Ophthalmol. 1996 Dec;80(12):1046-50 - PubMed
    1. Br J Ophthalmol. 1993 May;77(5):265-73 - PubMed
    1. Arch Ophthalmol. 1991 Sep;109(9):1242-57 - PubMed
    1. Arch Ophthalmol. 1986 May;104(5):702-5 - PubMed
    1. Retina. 1995;15(2):91-9 - PubMed

MeSH terms

LinkOut - more resources

Feedback